NCT06826014 TREC@TAMU Cancer Prevention Registry and Repository
| NCT ID | NCT06826014 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Texas A&M University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2025-03 |
| Primary Completion | 2030-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2025-03 with a primary completion date of 2030-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collects health and genetic information to implement cancer prevention and treatment strategies.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older, and, * People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and, * People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and, * Able to give and comprehend the consent process, and, * Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and, * Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and, * All sexes and gender identities. Exclusion Criteria: * Declines to participate or interact with staff/share their medical status. * A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06826014 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06826014 currently recruiting?
Yes, NCT06826014 is actively recruiting participants. Contact the research team at kramos@tamu.edu for enrollment information.
Where is the NCT06826014 trial being conducted?
This trial is being conducted at Bryan, United States.
Who is sponsoring the NCT06826014 clinical trial?
NCT06826014 is sponsored by Texas A&M University. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.